Resources from the same session
Case presentation - A patient with ALK+ NSCLC: How clinical characteristics, biopsy specimen and cfDNA can guide treatment decisions
Presenter: Laura Mezquita
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Integrated testing: The challenges we now face
Presenter: Keith Kerr
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Targeted therapy and immunotherapy: Can the patient have both?
Presenter: Anne-Marie Dingemans
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Rebiopsy and cfDNA in a complex and changing landscape
Presenter: Nicola Normanno
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Discussion
Session: More targets, more drugs, more choices, more conflicts
Resources:
Webcast